Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Cash Flow Reinvestment Rate
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd cash flow reinvestment rate. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (600332) has a Cash Flow Reinvestment Rate of 0.39x as of December 2025, reinvesting CN¥711.93 Million (capex CN¥330.65 Million plus investments CN¥381.27 Million) from operating cash flow of CN¥1.84 Billion. Explore 600332 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (2000–2025)
Cash flow reinvestment rate of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd from 2000 to 2025. Historical reinvestment intensity for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd across 24 annual periods. Explore 600332 capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Cash Flow Reinvestment Rate by Year (2000–2025)
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd cash flow reinvestment rate by year from 2000 to 2025. Year-by-year capital reinvestment analysis for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd. For the full cash flow conversion analysis, see 600332 cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 12.98x | CN¥3.38 Billion | CN¥260.23 Million | CN¥1.24 Billion | ▲ +649.2% |
| 2024 | 1.73x | CN¥5.96 Billion | CN¥3.44 Billion | CN¥1.13 Billion | ▲ +49.9% |
| 2023 | 1.16x | CN¥4.74 Billion | CN¥4.10 Billion | CN¥1.63 Billion | ▲ +6.2% |
| 2022 | 1.09x | CN¥7.62 Billion | CN¥7.00 Billion | CN¥1.38 Billion | ▲ +375.8% |
| 2021 | 0.23x | CN¥1.30 Billion | CN¥5.67 Billion | CN¥1.25 Billion | ▼ -90.3% |
| 2020 | 2.37x | CN¥1.39 Billion | CN¥585.19 Million | CN¥876.50 Million | ▲ +227.5% |
| 2019 | 0.72x | CN¥3.63 Billion | CN¥5.02 Billion | CN¥2.40 Billion | ▲ +314.7% |
| 2018 | 0.17x | CN¥909.71 Million | CN¥5.22 Billion | CN¥478.62 Million | ▼ -87.5% |
| 2017 | 1.40x | CN¥2.57 Billion | CN¥1.83 Billion | CN¥196.77 Million | ▲ +617.1% |
| 2016 | 0.20x | CN¥477.18 Million | CN¥2.44 Billion | CN¥228.03 Million | ▼ -52.6% |
| 2015 | 0.41x | CN¥800.01 Million | CN¥1.94 Billion | CN¥515.34 Million | ▲ +105.2% |
| 2014 | 0.20x | CN¥353.65 Million | CN¥1.76 Billion | CN¥353.65 Million | ▼ -23.3% |
| 2013 | 0.26x | CN¥350.35 Million | CN¥1.34 Billion | CN¥350.35 Million | ▲ +151.9% |
| 2012 | 0.10x | CN¥52.61 Million | CN¥506.53 Million | CN¥52.61 Million | ▼ -90.9% |
| 2010 | 1.14x | CN¥83.20 Million | CN¥73.17 Million | CN¥83.20 Million | ▲ +470.6% |
| 2009 | 0.20x | CN¥87.56 Million | CN¥439.39 Million | CN¥87.56 Million | ▼ -99.0% |
| 2008 | 20.80x | CN¥126.98 Million | CN¥6.10 Million | CN¥126.98 Million | ▲ +6271.7% |
| 2007 | 0.33x | CN¥122.69 Million | CN¥375.74 Million | CN¥122.69 Million | ▼ -86.0% |
| 2006 | 2.33x | CN¥90.45 Million | CN¥38.88 Million | CN¥90.45 Million | ▲ +173.7% |
| 2005 | 0.85x | CN¥124.36 Million | CN¥146.32 Million | CN¥124.36 Million | ▼ -44.8% |
| 2004 | 1.54x | CN¥308.69 Million | CN¥200.54 Million | CN¥308.69 Million | ▲ +49.8% |
| 2002 | 1.03x | CN¥173.70 Million | CN¥169.01 Million | CN¥173.70 Million | ▼ -10.2% |
| 2001 | 1.14x | CN¥160.44 Million | CN¥140.15 Million | CN¥160.44 Million | ▲ +100.9% |
| 2000 | 0.57x | CN¥163.53 Million | CN¥286.95 Million | CN¥163.53 Million | — |